Cited by 436Cardiovascular Function and Risk FactorsHeart Failure Treatment and ManagementCardiac Fibrosis and Remodeling

The DOI matches its Crossref record; 114 of the 114 references it cites were found in a registry or an index.

Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary

Open access

Shah, Sanjiv J., Borlaug, Barry A., Kitzman, Dalane W., McCulloch, Andrew D., Blaxall, Burns C., Agarwal, Rajiv, Chirinos, Julio A., Collins, Sheila, Deo, Rahul C., Gladwin, Mark T., Granzier, Henk, Hummel, Scott L., Kass, David A., Redfield, Margaret M., Sam, Flora, Wang, Thomas J., Desvigne-Nickens, Patrice, Adhikari, Bishow B.·2020·Circulation

DOI 10.1161/circulationaha.119.041886PMC PMC7101072

Open this paper in CoChat — free account

Abstract

Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is rising in prevalence, is associated with high morbidity and mortality and is considered to be the greatest unmet need in cardiovascular medicine today because of a general lack of effective treatments. To address this challenging syndrome, the National Heart, Lung, and Blood Institute convened a working group made up of experts in HFpEF and novel research methodologies to discuss research gaps and to prioritize research directions over the next decade. Here, we summarize the discussion of the working group, followed by key recommendations for future research priorities. There was uniform recognition that HFpEF is a highly integrated, multiorgan, systemic disorder requiring a multipronged investigative approach in both humans and animal models to improve understanding of mechanisms and treatment of HFpEF. It was recognized that advances in the understanding of basic mechanisms and the roles of inflammation, macrovascular and microvascular dysfunction, fibrosis, and tissue remodeling are needed and ideally would be obtained from (1) improved animal models, including large animal models, which incorporate the effects of aging and associated comorbid conditions; (2) repositories of deeply phenotyped physiological data and human tissue, made accessible to researchers to enhance collaboration and research advances; and (3) novel research methods that take advantage of computational advances and multiscale modeling for the analysis of complex, high-density data across multiple domains. The working group emphasized the need for interactions among basic, translational, clinical, and epidemiological scientists and across organ systems and cell types, leveraging different areas or research focus, and between research centers. A network of collaborative centers to accelerate basic, translational, and clinical research of pathobiological mechanisms and treatment strategies in HFpEF was discussed as an example of a strategy to advance research progress. This resource would facilitate comprehensive, deep phenotyping of a multicenter HFpEF patient cohort with standardized protocols and a robust biorepository. The research priorities outlined in this document are meant to stimulate scientific advances in HFpEF by providing a road map for future collaborative investigations among a diverse group of scientists across multiple domains.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.119.041886

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
Paulus, W. J., & Tschöpe, C. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.02.092 · Cited by 3,564
Machine Learning in Medicine
Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.115.001593 · Cited by 3,466
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
Antlanger, M., Aschauer, S., Kopecky, C., Hecking, M., Kovarik, J. J., Werzowa, J. M., Mascherbauer, J., Genser, B., Säemann, M. D., & Bonderman, D. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000473868 · Cited by 2,808
Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
Solomon, S. D., McMurray, J. J. V., Anand, I. S., Ge, J., Lam, C. S. P., Maggioni, A. P., Martinez, F., Packer, M., Pfeffer, M. A., Pieske, B., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908655 · Cited by 2,430
Self-citation
How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Pieske, B. M., Tschöpe, C., de Boer, R. A., Fraser, A. G., Anker, S. D., Donal, E., Edelmann, F., Fu, M. L. X., Guazzi, M., Lam, C. S. P., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz641 · Cited by 1,961
A Simple, Evidence-Based Approach to Help Guide Diagnosis of Heart Failure With Preserved Ejection Fraction
Reddy, Y. N. V., Carter, R. E., Obokata, M., Redfield, M. M., & Borlaug, B. A. (2018) · Circulation · doi:10.1161/circulationaha.118.034646 · Cited by 1,294
Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction
Obokata, M., Reddy, Y. N. V., Pislaru, S. V., Melenovsky, V., & Borlaug, B. A. (2017) · Circulation · doi:10.1161/circulationaha.116.026807 · Cited by 1,179
Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
González-López, E., Gallego‐Delgado, M., Guzzo-Merello, G., Moral, F. J. D. H.-D., Marcos, M. C., Robles, C., Bornstein, B., Salas, C., Lara‐Pezzi, E., Alonso‐Pulpón, L., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv338 · Cited by 1,176
Effect of Phosphodiesterase-5 Inhibition on Exercise Capacity and Clinical Status in Heart Failure With Preserved Ejection Fraction
Redfield, M. M., Chen, H. H., Borlaug, B. A., Semigran, M. J., Lee, K. L., Lewis, G. D., LeWinter, M. M., Rouleau, J. L., Bull, D. A., Mann, D. L., et al. (2013) · JAMA · doi:10.1001/jama.2013.2024 · Cited by 1,164
Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction
Shah, S. J., Katz, D. H., Selvaraj, S., Burke, M. A., Yancy, C. W., Gheorghiade, M., Bonow, R. O., Huang, C.-C., & Deo, R. C. (2015) · Circulation · doi:10.1161/circulationaha.114.010637 · Cited by 1,157
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Nishimura, R. A., Sorajja, P., Lam, C. S. P., & Redfield, M. M. (2010) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.930701 · Cited by 1,119
Fully Automated Echocardiogram Interpretation in Clinical Practice: Feasibility and Diagnostic Accuracy
Zhang, J., Gajjala, S., Agrawal, P., Tison, G. H., Hallock, L. A., Beussink-Nelson, L., Lassen, M. H., Fan, E., Aras, M. A., Jordan, C., et al. (2018) · Circulation · doi:10.1161/circulationaha.118.034338 · Cited by 1,006
Natriuretic Peptides, Their Receptors, and Cyclic Guanosine Monophosphate-Dependent Signaling Functions
Potter, L. R., Abbey‐Hosch, S. E., & Dickey, D. M. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0014 · Cited by 1,004
Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap
Shah, S. J., Kitzman, D. W., Borlaug, B. A., van Heerebeek, L., Zile, M. R., Kass, D. A., & Paulus, W. J. (2016) · Circulation · doi:10.1161/circulationaha.116.021884 · Cited by 1,003
A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor
Chinkers, M., Garbers, D. L., Chang, M., Lowe, D. G., Chin, H. R., Goeddel, D. V., & Schulz, S. (1989) · Nature · doi:10.1038/338078a0 · Cited by 992
Nitrosative stress drives heart failure with preserved ejection fraction
Schiattarella, G. G., Altamirano, F. J., Tong, D., French, K. M., Villalobos, E., Kim, S. Y., Luo, X., Jiang, N., May, H. I., Wang, Z. V., et al. (2019) · Nature · doi:10.1038/s41586-019-1100-z · Cited by 956
Chronic inhibition of cyclic GMP phosphodiesterase 5A prevents and reverses cardiac hypertrophy
Takimoto, E., Champion, H. C., Li, M., Belardi, D. F., Ren, S. V., Rodríguez, E. R., Bedja, D., Gabrielson, K. L., Wang, Y., & Kass, D. A. (2005) · Nature Medicine · doi:10.1038/nm1175 · Cited by 902
Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure With Preserved Ejection Fraction
Mohammed, S. F., Hussain, S., Mirzoyev, S. A., Edwards, W. D., Maleszewski, J. J., & Redfield, M. M. (2015) · Circulation · doi:10.1161/circulationaha.114.009625 · Cited by 874
Self-citation
Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes
Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872
Global Cardiovascular Reserve Dysfunction in Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Olson, T. P., Lam, C. S. P., Flood, K. S., Lerman, A., Johnson, B. D., & Redfield, M. M. (2010) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2010.03.077 · Cited by 733
Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic Resonance
Bellenger, N. G., Davies, C., Francis, J. M., Coats, A. J. S., & Pennell, D. J. (2000) · Journal of Cardiovascular Magnetic Resonance · doi:10.3109/10976640009148691 · Cited by 682
Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction: Contributions of Collagen and Titin
Zile, M. R., Baicu, C. F., S. Ikonomidis, J., Stroud, R. E., Nietert, P. J., Bradshaw, A. D., Slater, R., Palmer, B. M., Van Buren, P., Meyer, M., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013215 · Cited by 681
Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.
Waldman, S. A., Rapoport, R. M., & Murad, F. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)42597-x · Cited by 675
Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
Shah, S. J., Lam, C. S. P., Svedlund, S., Saraste, A., Hage, C., Tan, R.-S., Beussink-Nelson, L., Ljung Faxén, U., Fermer, M. L., Broberg, M. A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy531 · Cited by 656
Myocardial Structure and Function Differ in Systolic and Diastolic Heart Failure
van Heerebeek, L., Borbély, A., Niessen, H. W. M., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Linke, W. A., Laarman, G. J., & Paulus, W. J. (2006) · Circulation · doi:10.1161/circulationaha.105.587519 · Cited by 655
Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction
Westermann, D., Lindner, D., Kasner, M., Zietsch, C., Savvatis, K., Escher, F., von Schlippenbach, J., Skurk, C., Steendijk, P., Riad, A., et al. (2011) · Circulation Heart Failure · doi:10.1161/circheartfailure.109.931451 · Cited by 644
Importance of heart failure with preserved systolic function in patients ≥65 years of age
Kitzman, D. W., Gardin, J. M., Gottdiener, J. S., Arnold, A. M., Boineau, R., Aurigemma, G., Marino, E. K., Lyles, M. F., Cushman, M., & Enright, P. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01393-x · Cited by 634
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Franssen, C., Chen, H. S., Unger, A., Korkmaz, H. I., Keulenaer, G. W. D., Tschöpe, C., Leite-Moreira, A. F., Musters, R. J. P., Niessen, H. W. M., Linke, W. A., et al. (2015) · JACC Heart Failure · doi:10.1016/j.jchf.2015.10.007 · Cited by 615
RBM20, a gene for hereditary cardiomyopathy, regulates titin splicing
Guo, W., Schafer, S., Greaser, M. L., Radke, M. H., Liss, M., Govindarajan, T., Maatz, H., Schulz, H., Li, S., Parrish, A. M., et al. (2012) · Nature Medicine · doi:10.1038/nm.2693 · Cited by 589
Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease
Thadhani, R., Appelbaum, E. A., Pritchett, Y., Chang, Y., Wenger, J., Tamez, H. E., Bhan, I., Agarwal, R., Zoccali, C., Wanner, C., et al. (2012) · JAMA · doi:10.1001/jama.2012.120 · Cited by 572
Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction
Redfield, M. M., Anstrom, K. J., Levine, J. A., Koepp, G. A., Borlaug, B. A., Chen, H. H., LeWinter, M. M., Joseph, S. M., Shah, S. J., Semigran, M. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1510774 · Cited by 547
Low Myocardial Protein Kinase G Activity in Heart Failure With Preserved Ejection Fraction
van Heerebeek, L., Hamdani, N., Falcão‐Pires, I., Leite-Moreira, A. F., Begieneman, M. P. V., Bronzwaer, J. G. F., van der Velden, J., Stienen, G. J. M., Laarman, G. J., Somsen, G. A., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.076075 · Cited by 545
Natriuretic peptides: a new lipolytic pathway in human adipocytes
Sengenès, C., Berlan, M., de Glisezinski, I., Lafontan, M., & Galitzky, J. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.10.1345 · Cited by 531
Sex Differences in Cardiovascular Pathophysiology
Beale, A. L., Meyer, P., Marwick, T. H., Lam, C. S. P., & Kaye, D. M. (2018) · Circulation · doi:10.1161/circulationaha.118.034271 · Cited by 524
The kidney in heart failure: an update
Damman, K., & Testani, J. M. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv010 · Cited by 519
Cardiac macrophages promote diastolic dysfunction
Hulsmans, M., Sager, H. B., Roh, J. D., Valero‐Muñoz, M., Houstis, N. E., Iwamoto, Y., Sun, Y., Wilson, R. M., Wojtkiewicz, G. R., Tricot, B., et al. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20171274 · Cited by 508
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy
Nagueh, S. F., Shah, G., Wu, Y., Torre-Amione, G., King, N. M. P., Lahmers, S., Witt, C. C., Becker, K., Labeit, S., & Granzier, H. L. (2004) · Circulation · doi:10.1161/01.cir.0000135591.37759.af · Cited by 486
Prognostic Importance of Impaired Systolic Function in Heart Failure With Preserved Ejection Fraction and the Impact of Spironolactone
Shah, A. M., Claggett, B., Sweitzer, N. K., Shah, S. J., Anand, I. S., Liu, L., Pitt, B., Pfeffer, M. A., & Solomon, S. D. (2015) · Circulation · doi:10.1161/circulationaha.115.015884 · Cited by 478
Self-citation
Diastolic and Systolic Heart Failure Are Distinct Phenotypes Within the Heart Failure Spectrum
Borlaug, B. A., & Redfield, M. M. (2011) · Circulation · doi:10.1161/circulationaha.110.954388 · Cited by 451
Determinants of Exercise Intolerance in Elderly Heart Failure Patients With Preserved Ejection Fraction
Haykowsky, M. J., Brubaker, P. H., John, J. M., Stewart, K. P., Morgan, T. M., & Kitzman, D. W. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.055 · Cited by 447
Differential expression of cardiac titin isoforms and modulation of cellular stiffness
Cazorla, O., Freiburg, A., Helmes, M., Centner, T., McNabb, M., Wu, Y., Trombitás, K., Labeit, S., & Granzier, H. (2000) · Circulation Research · doi:10.1161/01.res.86.1.59 · Cited by 418
Self-citation
Prognostic Utility and Clinical Significance of Cardiac Mechanics in Heart Failure With Preserved Ejection Fraction
Freed, B. H., Daruwalla, V., Cheng, J., Aguilar, F. G., Beussink‐Nelson, L., Choi, A. D., Klein, D. A., Dixon, D., Baldridge, A. S., Rasmussen‐Torvik, L. J., et al. (2016) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.115.003754 · Cited by 413
Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction
Borlaug, B. A., Kane, G. C., Melenovský, V., & Olson, T. P. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw241 · Cited by 379
Temporal Relationship and Prognostic Significance of Atrial Fibrillation in Heart Failure Patients With Preserved Ejection Fraction
Zakeri, R., Chamberlain, A. M., Roger, V. L., & Redfield, M. M. (2013) · Circulation · doi:10.1161/circulationaha.113.001475 · Cited by 370
Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study
Pieske, B., Maggioni, A. P., Lam, C. S. P., Pieske-Kraigher, E., Filippatos, G., Butler, J., Ponikowski, P., Shah, S. J., Solomon, S. D., Scalise, A.-V., et al. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehw593 · Cited by 366
Self-citation
Effect of Endurance Training on the Determinants of Peak Exercise Oxygen Consumption in Elderly Patients With Stable Compensated Heart Failure and Preserved Ejection Fraction
Haykowsky, M. J., Brubaker, P. H., Stewart, K. P., Morgan, T. M., Eggebeen, J., & Kitzman, D. W. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.055 · Cited by 358
Self-citation
Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease
Lee, D. I., Zhu, G., Sasaki, T., Cho, G.-S., Hamdani, N., Holewinski, R., Jo, S.-H., Danner, T., Zhang, M., Rainer, P. P., et al. (2015) · Nature · doi:10.1038/nature14332 · Cited by 353
Self-citation
Global Pulmonary Vascular Remodeling in Pulmonary Hypertension Associated With Heart Failure and Preserved or Reduced Ejection Fraction
Fayyaz, A. U., Edwards, W. D., Maleszewski, J. J., Konik, E. A., DuBrock, H. M., Borlaug, B. A., Frantz, R. P., Jenkins, S. M., & Redfield, M. M. (2017) · Circulation · doi:10.1161/circulationaha.117.031608 · Cited by 353
Skeletal muscle abnormalities and exercise intolerance in older patients with heart failure and preserved ejection fraction
Kitzman, D. W., Nicklas, B. J., Kraus, W. E., Lyles, M. F., Eggebeen, J., Morgan, T. M., & Haykowsky, M. J. (2014) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00004.2014 · Cited by 345
Diastolic Dysfunction and Heart Failure With Preserved Ejection Fraction
Obokata, M., Reddy, Y. N. V., & Borlaug, B. A. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.12.034 · Cited by 324
Deterioration in right ventricular structure and function over time in patients with heart failure and preserved ejection fraction
Obokata, M., Reddy, Y. N. V., Melenovský, V., Pislaru, S. V., & Borlaug, B. A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy809 · Cited by 313
Identifying Pathophysiological Mechanisms in Heart Failure With Reduced Versus Preserved Ejection Fraction
Tromp, J., Westenbrink, B. D., Ouwerkerk, W., van Veldhuisen, D. J., Samani, N. J., Ponikowski, P. P., Metra, M., Anker, S. D., Cleland, J. G. F., Dickstein, K., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.050 · Cited by 312
Effect of Inorganic Nitrate on Exercise Capacity in Heart Failure With Preserved Ejection Fraction
Zamani, P., Rawat, D., Shiva-Kumar, P., Geraci, S., Bhuva, R., Konda, P., Doulias, P.-T., Ischiropoulos, H., Townsend, R. R., Margulies, K. B., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.012957 · Cited by 307
Assessing the Role of Circulating, Genetic, and Imaging Biomarkers in Cardiovascular Risk Prediction
Wang, T. J. (2011) · Circulation · doi:10.1161/circulationaha.109.912568 · Cited by 299
Prevalence, Clinical Phenotype, and Outcomes Associated With Normal B-Type Natriuretic Peptide Levels in Heart Failure With Preserved Ejection Fraction
Anjan, V. Y., Loftus, T. M., Burke, M. A., Akhter, N., Fonarow, G. C., Gheorghiade, M., & Shah, S. J. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.05.014 · Cited by 288
SIRT3-AMP-activated protein kinase activation by nitrite and metformin improves hyperglycemia and normalizes pulmonary hypertension associated with heart failure with preserved ejection fraction
Lai, Y.-C., Tabima, D. M., Dube, J. J., Hughan, K. S., Vanderpool, R. R., Goncharov, D. A., St. Croix, C. M., Garcia-Ocaña, A., Goncharova, E. A., Tofovic, S. P., et al. (2016) · Circulation · doi:10.1161/circulationaha.115.018935 · Cited by 270
Effect of Inorganic Nitrite vs Placebo on Exercise Capacity Among Patients With Heart Failure With Preserved Ejection Fraction
Borlaug, B. A., Anstrom, K. J., Lewis, G. D., Shah, S. J., Levine, J. A., Koepp, G. A., Givertz, M. M., Felker, G. M., LeWinter, M. M., Mann, D. L., et al. (2018) · JAMA · doi:10.1001/jama.2018.14852 · Cited by 268
The continuous heart failure spectrum: moving beyond an ejection fraction classification
Triposkiadis, F. K., Butler, J., Abboud, F. M., Armstrong, P. W., Adamopoulos, S. N., Atherton, J. J., Backs, J., Bauersachs, J. K., Burkhoff, D., Bonow, R. O., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz158 · Cited by 266
Lifetime Costs of Medical Care After Heart Failure Diagnosis
Dunlay, S. M., Shah, N. D., Shi, Q., Morlan, B. W., VanHouten, H., Long, K. H., & Roger, V. L. (2010) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.110.957225 · Cited by 264
Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction
de Boer, R. A., Nayor, M. G., deFilippi, C. R., Enserro, D. M., Bhambhani, V., Kizer, J. R., Blaha, M. J., Brouwers, F. P. J., Cushman, M., Lima, J. A. C., et al. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2017.4987 · Cited by 264
Arterial Stiffening With Exercise in Patients With Heart Failure and Preserved Ejection Fraction
Reddy, Y. N. V., Andersen, M. J., Obokata, M., Koepp, K. E., Kane, G. C., Melenovsky, V., Olson, T. P., & Borlaug, B. A. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.029 · Cited by 262
Expression of natriuretic peptide receptors in human adipose and other tissues
Sarzani, P., Dessı̀-Fulgheri, P., Paci, V. M., Espinosa, E., & RAPPELLI, A. (1996) · Journal of Endocrinological Investigation · doi:10.1007/bf03349021 · Cited by 254
Skeletal Muscle Composition and Its Relation to Exercise Intolerance in Older Patients With Heart Failure and Preserved Ejection Fraction
Haykowsky, M. J., Kouba, E., Brubaker, P. H., Nicklas, B. J., Eggebeen, J., & Kitzman, D. W. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2013.12.031 · Cited by 251
Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction
Hamdani, N., Bishu, K. G., von Frieling-Salewsky, M., Redfield, M. M., & Linke, W. A. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs353 · Cited by 234
CMR-Verified Diffuse Myocardial Fibrosis Is Associated With Diastolic Dysfunction in HFpEF
Su, M.-Y. M., Lin, L., Tseng, Y., Chang, C., Wu, C., Lin, J.-L., & Tseng, W. I. (2014) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2014.04.022 · Cited by 230
Association Between Hemodynamic Markers of Pulmonary Hypertension and Outcomes in Heart Failure With Preserved Ejection Fraction
Vanderpool, R. R., Saul, M. I., Nouraie, M. S., Gladwin, M. T., & Simon, M. A. M. (2018) · JAMA Cardiology · doi:10.1001/jamacardio.2018.0128 · Cited by 228
Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction
Schelbert, E. B., Fridman, Y., Wong, T. C., Daya, H. A., Piehler, K. M., Kadakkal, A., Miller, C., Ugander, M., Maanja, M., Kellman, P., et al. (2017) · JAMA Cardiology · doi:10.1001/jamacardio.2017.2511 · Cited by 220
Risk Factors for Incident Hospitalized Heart Failure With Preserved Versus Reduced Ejection Fraction in a Multiracial Cohort of Postmenopausal Women
Eaton, C. B., Pettinger, M. B., Rossouw, J. E., Martin, L. W., Foraker, R. E., Quddus, A., Liu, S., Wampler, N. S., Wu, W.-C., Manson, J. E., et al. (2016) · Circulation Heart Failure · doi:10.1161/circheartfailure.115.002883 · Cited by 217
Murine Models of Heart Failure With Preserved Ejection Fraction
Valero‐Muñoz, M., Backman, W., & Sam, F. (2017) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2017.07.013 · Cited by 217
Exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease
Gorter, T. M., Obokata, M., Reddy, Y. N. V., Melenovský, V., & Borlaug, B. A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy331 · Cited by 217
Multiple common comorbidities produce left ventricular diastolic dysfunction associated with coronary microvascular dysfunction, oxidative stress, and myocardial stiffening
Sorop, O., HEINONEN, I. H. A., van Kranenburg, M., van de Wouw, J., de Beer, V. J., Nguyen, I., Octavia, Y., van Duin, R. W. B., Stam, K., van Geuns, R., et al. (2018) · Cardiovascular Research · doi:10.1093/cvr/cvy038 · Cited by 213
Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction
Rommel, K., von Roeder, M., Latuscynski, K., Oberueck, C., Blazek, S., Fengler, K., Besler, C., Sandri, M., Lücke, C., Gutberlet, M., et al. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.02.018 · Cited by 211
Prognostic Importance of Pathophysiologic Markers in Patients With Heart Failure and Preserved Ejection Fraction
Burke, M. A., Katz, D. H., Beussink‐Nelson, L., Selvaraj, S., Gupta, D. K., Fox, J. M., Chakrabarti, S., Sauer, A. J., Rich, J. D., Freed, B. H., et al. (2013) · Circulation Heart Failure · doi:10.1161/circheartfailure.113.000854 · Cited by 209
Association of Chronic Kidney Disease with Abnormal Cardiac Mechanics and Adverse Outcomes in Patients with Heart Failure and Preserved Ejection Fraction
Unger, E. D., Dubin, R. F., Deo, R., Daruwalla, V., Friedman, J. L., Medina, C., Beussink‐Nelson, L., Freed, B. H., & Shah, S. J. (2015) · European Journal of Heart Failure · doi:10.1002/ejhf.445 · Cited by 198
A technique for in vivo mapping of myocardial creatine kinase metabolism
Haris, M., Singh, A. K., Cai, K., Kogan, F., McGarvey, J. R., DeBrosse, C., Zsido, G. A., Witschey, W. R. T., Koomalsingh, K. J., Pilla, J. J., et al. (2014) · Nature Medicine · doi:10.1038/nm.3436 · Cited by 196
The HFpEF Obesity Phenotype
Kitzman, D. W., & Shah, S. J. (2016) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.05.019 · Cited by 195
Sildenafil and B-Type Natriuretic Peptide Acutely Phosphorylate Titin and Improve Diastolic Distensibility In Vivo
Bishu, K. G., Hamdani, N., Mohammed, S. F., Krüger, M., Ohtani, T., Ogut, O., Brozovich, F. V., Burnett, J. C. J., Linke, W. A., & Redfield, M. M. (2011) · Circulation · doi:10.1161/circulationaha.111.048520 · Cited by 186
Heart Failure With Preserved Ejection Fraction
Loffredo, F. S., Nikolova, A., Pancoast, J. R., & Lee, R. T. (2014) · Circulation Research · doi:10.1161/circresaha.115.302929 · Cited by 184
Influence of sex and hormone status on circulating natriuretic peptides
Lam, C. S. P., Cheng, S., Choong, K., Larson, M. G., Murabito, J. M., Newton-Cheh, C., Bhasin, S., McCabe, E. L., Miller, K. K., Redfield, M. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.03.042 · Cited by 181
Lipid Mobilization with Physiological Atrial Natriuretic Peptide Concentrations in Humans
Birkenfeld, A. L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Franke, G., Berlan, M., Luft, F. C., Lafontan, M., & Jordan, J. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1953 · Cited by 165
A null mutation in SERPINE1 protects against biological aging in humans
Khan, S. S., Shah, S. J., Klyachko, E., Baldridge, A. S., Eren, M., Place, A. T., Aviv, A., Puterman, E., Lloyd-Jones, D. M., Heiman, M., et al. (2017) · Science Advances · doi:10.1126/sciadv.aao1617 · Cited by 157
Self-citation
Myocardial Injury and Cardiac Reserve in Patients With Heart Failure and Preserved Ejection Fraction
Obokata, M., Reddy, Y. N. V., Melenovsky, V., Kane, G. C., Olson, T. P., Jarolim, P., & Borlaug, B. A. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.04.039 · Cited by 151
Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine‐Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction
Kato, S., Saito, N., Kirigaya, H., Gyotoku, D., Iinuma, N., Kusakawa, Y., Iguchi, K., Nakachi, T., Fukui, K., Futaki, M., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002649 · Cited by 147
Experimentally Increasing Titin Compliance in a Novel Mouse Model Attenuates the Frank-Starling Mechanism But Has a Beneficial Effect on Diastole
Methawasin, M., Hutchinson, K. R., Lee, E., Smith, J. E., Saripalli, C., Hidalgo, C. G., Ottenheijm, C. A. C., & Granzier, H. L. M. (2014) · Circulation · doi:10.1161/circulationaha.113.005610 · Cited by 143
Myocardial Strain in the Assessment of Patients With Heart Failure
Marwick, T. H., Shah, S. J., & Thomas, J. D. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.0052 · Cited by 143
Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKD
Desai, A. S., Toto, R. D., Jarolı́m, P., Uno, H., Eckardt, K., Kewalramani, R., Levey, A. S., Lewis, E. F., McMurray, J. J. V., Parving, H., et al. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.05.020 · Cited by 141
Left ventricular hypertrophy in renal failure
Amann, K., Rychlík, I., Miltenberger-Miltény, G., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06818.x · Cited by 126
Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure with Preserved Ejection Fraction
Kanagala, P., Cheng, A. S. H., Singh, A., Khan, J. N., Gulsin, G. S., Patel, P., Gupta, P., Arnold, J. R., Squire, I. B., Ng, L. L., et al. (2019) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2018.11.031 · Cited by 126
Experimentally Increasing the Compliance of Titin Through RNA Binding Motif-20 (RBM20) Inhibition Improves Diastolic Function In a Mouse Model of Heart Failure With Preserved Ejection Fraction
Methawasin, M., Strom, J. G., Slater, R. E., Fernandez, V., Saripalli, C., & Granzier, H. L. M. (2016) · Circulation · doi:10.1161/circulationaha.116.023003 · Cited by 120
Enhancing natriuretic peptide signaling in adipose tissue, but not in muscle, protects against diet-induced obesity and insulin resistance
Wu, W., Shi, F., Liu, D., Ceddia, R. P., Gaffin, R. D., Wei, W., Fang, H., Lewandowski, E. D., & Collins, S. (2017) · Science Signaling · doi:10.1126/scisignal.aam6870 · Cited by 117
Predictive Value of Collagen Biomarkers for Heart Failure With and Without Preserved Ejection Fraction: MESA (Multi‐Ethnic Study of Atherosclerosis)
Duprez, D. A., Gross, M. D., Kizer, J. R., Ix, J. H., Hundley, W. G., & Jacobs, D. R. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.117.007885 · Cited by 112
Network Reconstruction and Systems Analysis of Cardiac Myocyte Hypertrophy Signaling
Ryall, K. A., Holland, D. O., Delaney, K. A., Kraeutler, M. J., Parker, A. J., & Saucerman, J. J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382937 · Cited by 110
An Integrative Translational Approach to Study Heart Failure with Preserved Ejection Fraction: A Position Paper from the Working Group on Myocardial Function of the European Society of Cardiology
Lourenço, A. P., Leite-Moreira, A. F., Balligand, J., Bauersachs, J. K., Dawson, D. K., de Boer, R. A., Windt, L. J. D., Falcão‐Pires, I., Fontes‐Carvalho, R., Franz, S., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.1059 · Cited by 109
Cardiovascular Effects of Unilateral Nephrectomy in Living Kidney Donors
Moody, W. E., Ferro, C. J., Edwards, N. C., Chue, C. D., Lin, E. L. S., Taylor, R. J., Cockwell, P., Steeds, R. P., & Townend, J. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06608 · Cited by 103
Ventricular–Arterial Coupling in Chronic Heart Failure
Chirinos, J. A., & Sweitzer, N. K. (2017) · Cardiac failure review · doi:10.15420/cfr.2017:4:2 · Cited by 95
Association of Low-Grade Albuminuria With Adverse Cardiac Mechanics
Katz, D. H., Selvaraj, S., Aguilar, F. G., Martinez, E. E., Beussink‐Nelson, L., Kim, K. A., Peng, J., Sha, J., Irvin, M. R., Eckfeldt, J. H., et al. (2013) · Circulation · doi:10.1161/circulationaha.113.003429 · Cited by 81
Effective Arterial Elastance Is Insensitive to Pulsatile Arterial Load
Chirinos, J. A., Rietzschel, E. R., Shiva‐Kumar, P., Buyzere, M. D., Zamani, P. L., Claessens, T. E., Geraci, S., Konda, P., Bacquer, D. D., Akers, S. R., et al. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03696 · Cited by 75
Racial Differences in Circulating Natriuretic Peptide Levels: The Atherosclerosis Risk in Communities Study
Gupta, D. K., Claggett, B. L., Wells, Q. S., Cheng, S. C., Li, M., Maruthur, N. M., Selvin, E., Coresh, J., Konety, S., Butler, K. R., et al. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.115.001831 · Cited by 74
Western Diet-Fed, Aortic-Banded Ossabaw Swine
Olver, T. D., Edwards, J. C., Jurrissen, T. J., Veteto, A. B., Jones, J. L., Gao, C., Rau, C., Warren, C. M., Klutho, P. J., Alex, L., et al. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2019.02.004 · Cited by 74
Prognostic significance of quantitative assessment of focal myocardial fibrosis in patients with heart failure with preserved ejection fraction
Kato, S., Saito, N., Kirigaya, H., Gyotoku, D., Iinuma, N., Kusakawa, Y., Iguchi, K., Nakachi, T., Fukui, K., Futaki, M., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.05.048 · Cited by 72
Heart Failure With Preserved Ejection Fraction Infrequently Evolves Toward a Reduced Phenotype in Long-Term Survivors
Lupón, J., Gavidia‐Bovadilla, G., Ferrer, E., de Antonio, M., Perera-Lluna, A., López‐Ayerbe, J., Domingo, M., Núñez, J. E., Zamora, E., Moliner, P., et al. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.118.005652 · Cited by 71
Pharmacokinetics and Pharmacodynamics of Inorganic Nitrate in Heart Failure With Preserved Ejection Fraction
Zamani, P. L., Tan, V., Soto‐Calderon, H., Beraun, M., Brandimarto, J., Trieu, L., Varakantam, S., Doulias, P., Townsend, R. R., Chittams, J. L., et al. (2016) · Circulation Research · doi:10.1161/circresaha.116.309832 · Cited by 62
An NPPB Promoter Polymorphism Associated With Elevated N‐Terminal pro–B‐Type Natriuretic Peptide and Lower Blood Pressure, Hypertension, and Mortality
Seidelmann, S. B., Vardeny, O., Claggett, B. L., Yu, B., Shah, A. M., Ballantyne, C. M., Selvin, E., MacRae, C. A., Boerwinkle, E., & Solomon, S. D. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.116.005257 · Cited by 58
Heart Failure, Left Ventricular Remodeling, and Circulating Nitric Oxide Metabolites
Chirinos, J. A., Akers, S. R., Trieu, L., Ischiropoulos, H., Doulias, P., Tariq, A., Vasim, I., Koppula, M. R., Syed, A. A., Soto‐Calderon, H., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.116.004133 · Cited by 54
β-Adrenergic and Atrial Natriuretic Peptide Interactions on Human Cardiovascular and Metabolic Regulation
Birkenfeld, A. L., Boschmann, M., Moro, C., Adams, F., Heusser, K., Tank, J., Diedrich, A., Schroeder, C., Franke, G., Berlan, M., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1084 · Cited by 53
Innovative Clinical Trial Designs for Precision Medicine in Heart Failure with Preserved Ejection Fraction
Shah, S. J. (2017) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-017-9759-8 · Cited by 42
Alternative Splicing of Titin Restores Diastolic Function in an HFpEF-Like Genetic Murine Model ( Ttn ΔIAjxn )
Bull, M. M., Methawasin, M., Strom, J. G., Nair, P., Hutchinson, K. R., & Granzier, H. L. M. (2016) · Circulation Research · doi:10.1161/circresaha.116.308904 · Cited by 40
Systems Biophysics: Multiscale Biophysical Modeling of Organ Systems
McCulloch, A. D. (2016) · Biophysical Journal · doi:10.1016/j.bpj.2016.02.007 · Cited by 27
Cardiac Extracellular Matrix is Associated with Adverse Outcome in Patients with Chronic Heart Failure
Duca, F., Zotter‐Tufaro, C., Kammerlander, A. A., Panzenboeck, A., Aschauer, S., Dalos, D., Koell, B., Börries, B., Agis, H., Kain, R., et al. (2016) · European Journal of Heart Failure · doi:10.1002/ejhf.680 · Cited by 24
Mouse Genome-Wide Association Study of Preclinical Group II Pulmonary Hypertension Identifies Epidermal Growth Factor Receptor
Kelly, N. J., Radder, J. E., Baust, J., Burton, C. L., Lai, Y., Potoka, K. C., Agostini, B., Wood, J. P., Bachman, T. N., Vanderpool, R. R., et al. (2017) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0176oc · Cited by 23
The role of BAT in cardiometabolic disorders and aging
Blondin, D. P., & Carpentier, A. C. (2016) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2016.09.002 · Cited by 17
Atlas-based anatomical modeling and analysis of heart disease
Medrano−Gracia, P., Cowan, B. R., Suinesiaputra, A., & Young, A. A. (2014) · Drug Discovery Today Disease Models · doi:10.1016/j.ddmod.2014.05.002 · Cited by 11
Phenotypic Persistence in Heart Failure With Preserved Ejection Fraction
Paulus, W. J. (2019) · Circulation Heart Failure · doi:10.1161/circheartfailure.119.005956 · Cited by 9
Cardiac Natriuretic Peptides: Contributors to Cardiac Cachexia or Possible Anti-obesity Agents or Both?
Costello‐Boerrigter, L. C. (2012) · Diabetes · doi:10.2337/db12-0763 · Cited by 7

Flagged first, then by citations

Sorted by citations

Heart Failure With Preserved Ejection Fraction: A Review
Redfield, M. M., & Borlaug, B. A. (2023) · JAMA · doi:10.1001/jama.2023.2020 · Cited by 662
Cellular and molecular pathobiology of heart failure with preserved ejection fraction
Mishra, S., & Kass, D. A. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-020-00480-6 · Cited by 437
From Systemic Inflammation to Myocardial Fibrosis
Paulus, W. J., & Zile, M. R. (2021) · Circulation Research · doi:10.1161/circresaha.121.318159 · Cited by 413
Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials
Butler, J., Shah, S. J., Petrie, M. C., Borlaug, B. A., Abildstrøm, S. Z., Davies, M. J., Hovingh, G. K., Kitzman, D. W., Møller, D. V., Verma, S., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00469-0 · Cited by 386
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J. T., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 388

See all 436

Authors: Shah, S. J., Borlaug, B. A., Kitzman, D. W., McCulloch, A. D., Blaxall, B. C., Agarwal, R., Chirinos, J. A., Collins, S., Deo, R. C., Gladwin, M. T., Granzier, H., Hummel, S. L., Kass, D. A., Redfield, M. M., Sam, F., Wang, T. J., Desvigne-Nickens, P., & Adhikari, B. B.
Affiliations: Northwestern University (US)
Mayo Clinic (US)
Wake Forest University Health Sciences (US)
University of California San Diego (US)
Christ Hospital (US)
Indiana University Indianapolis (US)
University of Pennsylvania (US)
Vanderbilt University (US)
Brigham and Women's Hospital (US)
University of Pittsburgh (US)
University of Arizona (US)
University of Michigan (US)
Johns Hopkins University (US)
Boston University (US)
National Institutes of Health (US)
ORCID: Shah, Sanjiv J.
Borlaug, Barry A.
Kitzman, Dalane W.
McCulloch, Andrew D.
Agarwal, Rajiv
Chirinos, Julio A.
Collins, Sheila
Deo, Rahul C.
Gladwin, Mark T.
Granzier, Henk
Hummel, Scott L.
Kass, David A.
Redfield, Margaret M.
Sam, Flora
Wang, Thomas J.
Desvigne-Nickens, Patrice
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2020-03-24
Volume: 141
Issue: 12
Pages: 1001-1026
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.119.041886
PMC: PMC7101072
OpenAlex: W3012616651
Cited by: 436
References: 114
Citations by year: 2026: 53 · 2025: 74 · 2024: 74 · 2023: 67 · 2022: 99 · 2021: 49 · 2020: 19
FWCI: 9.93
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institute on Aging (R01AG018915, R01AG045551, R01AG058969, P30AG021332, U24AG059624)
National Heart, Lung, and Blood Institute (R01HL128526, R61HL146390, R01HL118524, U01HL125175, R01HL127028, R01HL144657, R01HL104106, R01HL126638, U10HL110262, R01HL149423, DP2HL123228, R35HL135827, P01HL103455, R01HL117153, R01HL140731, P01HL094307, R01HL132551, U01HL125205, R01HL133695, R01HL121510, R01HL107577, R56HL136730, R01HL134321, R01HL125886, R01HL098032, T32HL110849)
National Cancer Institute (K12CA090625)
National Institute of Diabetes and Digestive and Kidney Diseases (R01DK103056, P50DK096418)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart Failure Treatment and Management
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
Keywords: heart failure with preserved ejection fraction, research priorities, research gaps, animal models, inflammation, microvascular dysfunction, macrovascular dysfunction, fibrosis, tissue remodeling, biorepository, multiscale modeling, translational research
MeSH terms: Heart Failure, Humans, Research, Stroke Volume, United States, National Heart, Lung, and Blood Institute (U.S.)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Research Priorities for Heart Failure With Preserved Ejection Fraction: National Heart, Lung, and Blood Institute Working Group Summary

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks